Preview

Systemic Hypertension

Advanced search

Perivascular adipose tissue and its role in the development of cardiovascular diseases

https://doi.org/10.38109/2075-082X-2025-1-13-17

Abstract

Perivascular adipose tissue (RVT) is an important component of the vascular system, which is actively involved in the pathogenesis of cardiovascular diseases (CVD). This review is based on an analysis of clinical studies from the PubMed, Embase, Web of Science, and e-Library databases aimed at studying the mechanisms through which RVT affects the development of CVD. It has been proven that prostate is a source of various pro-inflammatory cytokines, such as TNF-α, IL-6 and MCP-1. These molecules contribute to the activation of inflammatory processes, which can lead to endothelial damage and the development of atherosclerosis. An increase in the volume of the pancreas is associated with an increase in the level of inflammatory markers in the blood, which indicates systemic inflammation. RVT is involved in the metabolism of lipids and glucose, and its excessive accumulation can lead to insulin resistance. This condition is associated with an increased risk of developing type 2 diabetes and CVD. Adipokines such as leptin and adiponectin play a key role in regulating metabolism. Low levels of adiponectin secreted by the pancreas are associated with an increased risk of CVD. RVT affects vascular tone and their response to vasodilators and vasoconstrictors. Changes in the function of the pancreas can lead to impaired regulation of blood pressure and increase the risk of atherosclerosis; promote vascular remodeling, which is also associated with the development of atherosclerosis. RVT is often associated with other risk factors such as obesity, dyslipidemia, and metabolic syndrome. These factors interact with each other, creating a complex network that contributes to the development of CVD. Genetic predispositions and epigenetic changes can also affect the development of the pancreas and its functions. Some studies indicate a link between genetic markers and the level of RVT, which may explain individual differences in the risk of CVD. Thus, RVT plays an important role in the pathogenesis of cardiovascular diseases through the mechanisms of inflammation, metabolic dysfunction, and changes in vascular function. Understanding these mechanisms can help in the development of new approaches to the prevention and treatment of CVD, as well as in identifying potential targets for therapeutic intervention. Further research is needed to better understand the role of RVT in cardiovascular health.

About the Authors

L. D. Khidirova
Novosibirsk State Medical University ; Novosibirsk Regional Clinical Cardiology Dispensary
Russian Federation

Lyudmila D. Khidirova, Dr. of Sci. (Med.), Professor, Department of Pharmacology, Clinical Pharmacology and Evidence-Based Medicine; Leading Cardiologist

52 Krasny Prospekt, Novosibirsk 630091

6/8 Zalesskogo Street, Novosibirsk 630047



V. V. Kovalenko
Novosibirsk State Medical University
Russian Federation

Valeria V. Kovalenko, student 

52 Krasny Prospekt, Novosibirsk 630091



A. V. Kuzakova
Novosibirsk State Medical University
Russian Federation

Anastasia V. Kuzakova, student 

52 Krasny Prospekt, Novosibirsk 630091



References

1. Ahmed A, Bibi A, Valoti M, Fusi F. Perivascular Adipose Tissue and Vascular Smooth Muscle Tone: Friends or Foes? Cells. 2023 Apr 20;12(8):1196. PMID: 37190105; PMCID: PMC10136477. https://doi.org/10.3390/cells12081196

2. Podzolkov V. I., Bragina A. E., Osadchiy K. K., Rodionova Yu.N., Jafarova Z.B., Lobanova M.V., Larionova Yu.S. Relationship between the volume of perivascular adipose tissue and the vascular wall lesion. Cardiovascular Therapy and Prevention. 2021;20(7):2993. (In Russ.) https://doi.org/10.15829/1728-8800-2021-2993

3. Stanek A, Brożyna-Tkaczyk K, Myśliński W. The Role of Obesity-Induced Perivascular Adipose Tissue (PVAT) Dysfunction in Vascular Homeostasis. Nutrients. 2021 Oct 28;13(11):3843. PMID: 34836100; PMCID: PMC8621306. https://doi.org/10.3390/nu13113843

4. Kim O. T., Dadaeva V. A., Korolev A. I., & Drapkina O. M. [Kim O. T., Dadaeva V.A., Korolev A.I., Drapkina O. M. Perivascular adipose tissue in the pathogenesis of cardiovascular disease. Russian Journal of Cardiology. 2021;26(11):4567. (In Russ) https://doi.org/10.15829/1560-4071-2021-4567

5. Cai M, Zhao D, Han X, Han S, Zhang W, Zang Z, Gai C, Rong R, Gao T. The role of perivascular adipose tissue-secreted adipocytokines in cardiovascular disease. Front Immunol. 2023 Sep 26;14:1271051. PMID: 37822930; PMCID: PMC10562567. https://doi.org/10.3389/fimmu.2023.1271051

6. Tong Y, Zuo Z, Li X, Li M, Wang Z, Guo X, Wang X, Sun Y, Chen D, Zhang Z. Protective role of perivascular adipose tissue in the cardiovascular system. Front Endocrinol (Lausanne). 2023 Dec 8;14:1296778. PMID: 38155947; PMCID: PMC10753176. https://doi.org/10.3389/fendo.2023.1296778

7. Grigoras A, Amalinei C, Balan RA, Giusca SE, Caruntu ID. Perivascular adipose tissue in cardiovascular diseases-an update. Anatol J Cardiol. 2019 Nov;22(5):219-231. PMID: 31674938; PMCID: PMC6955067. https://doi.org/10.14744/AnatolJCardiol.2019.91380

8. Kim HW, Shi H, Winkler MA, Lee R, Weintraub NL. Perivascular Adipose Tissue and Vascular Perturbation/ Atherosclerosis. Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2569-2576. Epub 2020 Sep 3. PMID: 32878476; PMCID: PMC7577939. https://doi.org/10.1161/ATVBAHA.120.312470

9. Nosalski R, Guzik TJ. Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol. 2017 Oct;174(20):3496-3513. Epub 2017 Feb 9. PMID: 28063251; PMCID: PMC5610164. https://doi.org/10.1111/bph.13705

10. Mazzotta C, Basu S, Gower AC, Karki S, Farb MG, Sroczynski E, Zizza E, Sarhan A, Pande AN, Walsh K, Dobrilovic N, Gokce N. Perivascular Adipose Tissue Inflammation in Ischemic Heart Disease. Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):1239-1250. Epub 2021 Jan 28. PMID: 33504180; PMCID: PMC7904602. https://doi.org/10.1161/ATVBAHA.120.315865

11. Yu Z, Han S, Cao X, Zhu C, Wang X, Guo X. Genetic polymorphisms in adipokine genes and the risk of obesity: a systematic review and meta-analysis. Obesity (Silver Spring). 2012 Feb;20(2):396-406. Epub 2011 Jun 9. PMID: 21660081. https://doi.org/10.1038/oby.2011.148

12. Shramko II, Ageeva ES, Maliy KD, Repinskaya IN, Tarimov CO, Fomochkina II, Kubishkin AV, Ostapenko OV, Gurtovaya AK, Shekhar S. Association between Adiponectin and Leptin Receptor Genetic Polymorphisms and Clinical Manifestations of Metabolic Syndrome. J Diabetes Res. 2022 Sep 8;2022:9881422. PMID: 36117520; PMCID: PMC9477633. https://doi.org/10.1155/2022/9881422

13. DeVallance ER, Branyan KW, Olfert IM, Pistilli EE, Bryner RW, Kelley EE, Frisbee JC, Chantler PD. Chronic stress induced perivascular adipose tissue impairment of aortic function and the therapeutic effect of exercise. Exp Physiol. 2021 Jun;106(6):1343-1358. Epub 2021 May 14. PMID: 33913209; PMCID: PMC8169624. https://doi.org/10.1113/EP089449

14. Cheng CK, Ding H, Jiang M, Yin H, Gollasch M, Huang Y. Perivascular adipose tissue: Fine-tuner of vascular redox status and inflammation. Redox Biol. 2023 Jun;62:102683. Epub 2023 Mar 20. PMID: 36958248; PMCID: PMC10038789. https://doi.org/10.1016/j.redox.2023.102683

15. Antoniades C, Tousoulis D, Vavlukis M, Fleming I, Duncker DJ, Eringa E, Manfrini O, Antonopoulos AS, Oikonomou E, Padró T, Trifunovic-Zamaklar D, De Luca G, Guzik T, Cenko E, Djordjevic-Dikic A, Crea F. Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers. Eur Heart J. 2023 Oct 12;44(38):3827-3844. PMID: 37599464; PMCID: PMC10568001. https://doi.org/10.1093/eurheartj/ehad484

16. Sigdel S, Udoh G, Albalawy R, Wang J. Perivascular Adipose Tissue and Perivascular Adipose TissueDerived Extracellular Vesicles: New Insights in Vascular Disease. Cells. 2024 Aug 6;13(16):1309. PMID: 39195199; PMCID: PMC11353161. https://doi.org/10.3390/cells13161309

17. Valentini A, Cardillo C, Della Morte D, Tesauro M. The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus. Biomedicines. 2023 Nov 9;11(11):3006. PMID: 38002006; PMCID: PMC10669084. https://doi.org/10.3390/biomedicines11113006

18. Agabiti-Rosei C, Saxton SN, De Ciuceis C, Lorenza Muiesan M, Rizzoni D, Agabiti Rosei E, Heagerty AM. Influence of Perivascular Adipose Tissue on Microcirculation: A Link Between Hypertension and Obesity. Hypertension. 2024 Jan;81(1):24-33. Epub 2023 Nov 8. PMID: 37937425. https://doi.org/10.1161/HYPERTENSIONAHA.123.19437

19. Sowka A, Dobrzyn P. Role of Perivascular Adipose Tissue-Derived Adiponectin in Vascular Homeostasis. Cells. 2021 Jun 12;10(6):1485. PMID: 34204799; PMCID: PMC8231548. https://doi.org/10.3390/cells10061485

20. Hillock-Watling C, Gotlieb AI. The pathobiology of perivascular adipose tissue (PVAT), the fourth layer of the blood vessel wall. Cardiovasc Pathol. 2022 Nov-Dec;61:107459. Epub 2022 Jul 28. PMID: 35907442. https://doi.org/10.1016/j.carpath.2022.107459


Review

For citations:


Khidirova L.D., Kovalenko V.V., Kuzakova A.V. Perivascular adipose tissue and its role in the development of cardiovascular diseases. Systemic Hypertension. 2025;22(1):13-17. (In Russ.) https://doi.org/10.38109/2075-082X-2025-1-13-17

Views: 171


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)